Stratec SE (0RAR.L)
EUR 23.02
(-0.04%)
EUR 23.02
(-0.04%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 246.2 Million EUR | 42.88% |
| 2022 | 172.32 Million EUR | 5.87% |
| 2021 | 162.76 Million EUR | 2.14% |
| 2020 | 159.35 Million EUR | 13.5% |
| 2019 | 140.4 Million EUR | 14.08% |
| 2018 | 123.08 Million EUR | 16.18% |
| 2017 | 105.93 Million EUR | -7.27% |
| 2016 | 114.24 Million EUR | 298.65% |
| 2015 | 28.65 Million EUR | 11.53% |
| 2014 | 25.69 Million EUR | 24.69% |
| 2013 | 20.6 Million EUR | -30.97% |
| 2012 | 29.85 Million EUR | 7.52% |
| 2011 | 27.76 Million EUR | 3.0% |
| 2010 | 26.95 Million EUR | 1.73% |
| 2009 | 26.49 Million EUR | 32.07% |
| 2008 | 20.06 Million EUR | 9.67% |
| 2007 | 18.29 Million EUR | 7.7% |
| 2006 | 16.98 Million EUR | 40.33% |
| 2005 | 12.1 Million EUR | 19.05% |
| 2004 | 10.16 Million EUR | -6.63% |
| 2003 | 10.88 Million EUR | 106174.34% |
| 2002 | 10.24 Thousand EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 223.08 Million EUR | 1.68% |
| 2024 Q2 | 219.39 Million EUR | 0.24% |
| 2024 Q1 | 218.86 Million EUR | -11.11% |
| 2023 Q3 | 217.25 Million EUR | 4.85% |
| 2023 FY | 246.2 Million EUR | 42.88% |
| 2023 Q1 | 176.24 Million EUR | 2.28% |
| 2023 Q2 | 207.21 Million EUR | 17.58% |
| 2023 Q4 | 246.2 Million EUR | 13.32% |
| 2022 FY | 172.32 Million EUR | 5.87% |
| 2022 Q1 | 169.37 Million EUR | 4.06% |
| 2022 Q2 | 181.03 Million EUR | 6.88% |
| 2022 Q3 | 183.96 Million EUR | 1.62% |
| 2022 Q4 | 172.32 Million EUR | -6.33% |
| 2021 Q1 | 173.47 Million EUR | 8.86% |
| 2021 FY | 162.76 Million EUR | 2.14% |
| 2021 Q2 | 174.24 Million EUR | 0.45% |
| 2021 Q3 | 167.77 Million EUR | -3.71% |
| 2021 Q4 | 162.76 Million EUR | -2.98% |
| 2020 FY | 159.35 Million EUR | 13.5% |
| 2020 Q1 | 159.45 Million EUR | 13.57% |
| 2020 Q2 | 155.42 Million EUR | -2.53% |
| 2020 Q3 | 159.91 Million EUR | 2.89% |
| 2020 Q4 | 159.35 Million EUR | -0.35% |
| 2019 FY | 140.4 Million EUR | 14.08% |
| 2019 Q3 | 149.26 Million EUR | 4.64% |
| 2019 Q2 | 142.64 Million EUR | 1.18% |
| 2019 Q4 | 140.4 Million EUR | -5.93% |
| 2019 Q1 | 140.98 Million EUR | 14.54% |
| 2018 Q1 | 109.01 Million EUR | 2.91% |
| 2018 FY | 123.08 Million EUR | 16.18% |
| 2018 Q4 | 123.08 Million EUR | 2.06% |
| 2018 Q2 | 118.74 Million EUR | 8.92% |
| 2018 Q3 | 120.6 Million EUR | 1.56% |
| 2017 Q1 | 110.57 Million EUR | -3.22% |
| 2017 FY | 105.93 Million EUR | -7.27% |
| 2017 Q4 | 105.93 Million EUR | -0.91% |
| 2017 Q3 | 106.91 Million EUR | -3.86% |
| 2017 Q2 | 111.21 Million EUR | 0.58% |
| 2016 Q4 | 114.24 Million EUR | -4.91% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 113.48 Million EUR | 0.0% |
| 2016 FY | 114.24 Million EUR | 298.65% |
| 2016 Q3 | 120.14 Million EUR | 5.87% |
| 2015 Q4 | 28.65 Million EUR | -4.75% |
| 2015 Q1 | 35.36 Million EUR | 37.63% |
| 2015 FY | 28.65 Million EUR | 11.53% |
| 2015 Q2 | 32.6 Million EUR | -7.8% |
| 2015 Q3 | 30.08 Million EUR | -7.72% |
| 2014 Q3 | 24.12 Million EUR | -2.79% |
| 2014 FY | 25.69 Million EUR | 24.69% |
| 2014 Q1 | 25.9 Million EUR | 25.69% |
| 2014 Q4 | 25.69 Million EUR | 6.5% |
| 2014 Q2 | 24.82 Million EUR | -4.18% |
| 2013 Q3 | 31.46 Million EUR | 8.8% |
| 2013 Q1 | 32.86 Million EUR | 10.08% |
| 2013 FY | 20.6 Million EUR | -30.97% |
| 2013 Q4 | 20.6 Million EUR | -34.51% |
| 2013 Q2 | 28.92 Million EUR | -11.99% |
| 2012 Q3 | 30.39 Million EUR | -2.97% |
| 2012 Q4 | 29.85 Million EUR | -1.77% |
| 2012 Q2 | 31.32 Million EUR | 0.65% |
| 2012 Q1 | 31.11 Million EUR | 12.07% |
| 2012 FY | 29.85 Million EUR | 7.52% |
| 2011 Q4 | 27.76 Million EUR | -21.31% |
| 2011 Q2 | 33.35 Million EUR | 6.64% |
| 2011 Q3 | 35.28 Million EUR | 5.8% |
| 2011 FY | 27.76 Million EUR | 3.0% |
| 2011 Q1 | 31.27 Million EUR | 16.02% |
| 2010 FY | 26.95 Million EUR | 1.73% |
| 2010 Q1 | 30.12 Million EUR | 13.68% |
| 2010 Q3 | 33.34 Million EUR | 4.11% |
| 2010 Q4 | 26.95 Million EUR | -19.15% |
| 2010 Q2 | 32.02 Million EUR | 6.31% |
| 2009 FY | 26.49 Million EUR | 32.07% |
| 2009 Q4 | 26.49 Million EUR | 0.0% |
| 2008 FY | 20.06 Million EUR | 9.67% |
| 2007 FY | 18.29 Million EUR | 7.7% |
| 2006 FY | 16.98 Million EUR | 40.33% |
| 2005 FY | 12.1 Million EUR | 19.05% |
| 2004 FY | 10.16 Million EUR | -6.63% |
| 2003 FY | 10.88 Million EUR | 106174.34% |
| 2002 FY | 10.24 Thousand EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cegedim SA | 629.51 Million EUR | 60.89% |
| Guerbet SA | 646.97 Million EUR | 61.945% |
| Nexus AG | 153.13 Million EUR | -60.777% |
| Bastide Le Confort Médical SA | 566.34 Million EUR | 56.527% |
| Revenio Group Oyj | 37.6 Million EUR | -554.801% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 86.671% |
| Sartorius Aktiengesellschaft | 6.99 Billion EUR | 96.482% |
| LNA Santé SA | 1.19 Billion EUR | 79.459% |
| Siemens Healthineers AG | 28.55 Billion EUR | 99.138% |
| Medios AG | 125.94 Million EUR | -95.485% |
| Equasens Société anonyme | 166.41 Million EUR | -47.943% |